IFAM
HQL

Institutional & Family Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Institutional & Family Asset Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$2K – 854
2019
Q1 		$2K Buy
+100
New +$1.73K ﹤0.01% 719

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Institutional & Family Asset Management's HQL Position: Q2 2019 in Review

Institutional & Family Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q2 2019, closing a stake of 100 shares — an estimated $2K sold.

Institutional & Family Asset Management first reported a position in HQL in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 55 funds tracked by Wall St. Rank hold HQL as of Q2 2019.

  • Institutional & Family Asset Management reported no remaining abrdn Life Sciences Investors position as of Q2 2019 after selling out during the quarter.
  • Institutional & Family Asset Management sold 100 abrdn Life Sciences Investors shares in Q2 2019, an estimated $2K.
  • Institutional & Family Asset Management first reported a position in abrdn Life Sciences Investors in Q1 2019 and held it in 1 quarter.
  • Institutional & Family Asset Management's abrdn Life Sciences Investors position peaked at $2K in Q1 2019.
  • 55 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2019.

Based on Institutional & Family Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.